by winston | Nov 21, 2019 | 2019, News
Board Realignment Follows SWK’s Acquisition of Enteris BioPharma Dallas, TX, November 21, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that Winston Black, Chief Executive Officer...
by winston | Nov 18, 2019 | 2019, News
Corporate HighlightsAcquired Enteris BioPharma, Inc. (“Enteris”) a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence®Enteris to operate as an independent, wholly-owned subsidiary of...
by winston | Sep 16, 2019 | 2019, News, Uncategorized
SWK Holdings to Present at the Fall Investor Summit Presentation Scheduled for Today, September 16, 2019, at 4:30 p.m., ET Dallas, TX, September 16, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company,...
by winston | Sep 6, 2019 | 2019, News, Uncategorized
Dallas, TX, September 6, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of...
by winston | Sep 3, 2019 | 2019, News
SWK Expands Board of Directors to Meet NASDAQ Listing RequirementsDallas, TX – September 3, 2019 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that the Company has submitted its formal...
by winston | Aug 27, 2019 | 2019, News
SWK Holdings Corporation acquires 100% of Enteris’ equityEnteris to operate as an independent, wholly-owned subsidiary of SWK, targeting opportunities to develop and advance orally delivered peptide and small molecule therapeuticsNatural extension of SWK’s life...
